Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending September 30, 2022 was -0.66 (a -287.15% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -128.33%
- Annual Net Debt/EBITDA for 2021 was 0.65 (a -73.2% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was 2.42 (a -285.33% decrease from previous year)
- Annual Net Debt/EBITDA for 2019 was -1.3 (a 25.24% increase from previous year)
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Biodesix, Inc.
Most recent Net Debt/EBITDAof BDSX including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Biodesix, Inc.
Biodesix, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -0.66 | 0.35 | 0.52 | – |
| 2021 | 2.33 | 1.6 | 2.48 | 4.67 | 0.65 |
| 2020 | 20.56 | -15.05 | 0.0 | 0.0 | 2.42 |
| 2019 | – | – | -16.0 | 0.0 | -1.3 |
| 2018 | – | – | – | – | -1.04 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research